The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 27, 2021
Filed:
Nov. 08, 2017
Applicant:
Novomedix, Llc, San Diego, CA (US);
Inventors:
Leah M. Fung, San Diego, CA (US);
Kyle W. H. Chan, San Diego, CA (US);
Robert W. Sullivan, Vista, CA (US);
Cathy A. Swindlehurst, San Diego, CA (US);
Assignee:
NovoMedix, LLC, San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 279/04 (2006.01); A61K 31/426 (2006.01); A61K 31/427 (2006.01); A61K 31/702 (2006.01); A61K 31/70 (2006.01); A61K 31/4985 (2006.01); A61K 31/522 (2006.01); A61K 31/64 (2006.01); A61K 38/26 (2006.01); A61K 31/4439 (2006.01); A61P 9/00 (2006.01); A61P 3/10 (2006.01); A61P 9/12 (2006.01); A61K 9/28 (2006.01); A61K 31/155 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07C 279/04 (2013.01); A61K 9/28 (2013.01); A61K 31/155 (2013.01); A61K 31/426 (2013.01); A61K 31/427 (2013.01); A61K 31/4439 (2013.01); A61K 31/4985 (2013.01); A61K 31/522 (2013.01); A61K 31/64 (2013.01); A61K 31/70 (2013.01); A61K 31/702 (2013.01); A61K 38/26 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2018.01); A61P 9/00 (2018.01); A61P 9/12 (2018.01); C07B 2200/13 (2013.01);
Abstract
Provided herein are nitrite salts of 1,1-dimethylbiguanide; and isotopic variants thereof; and pharmaceutically acceptable hydrates and solvates thereof. Also provided herein are their pharmaceutical compositions and methods of use for treating, preventing, or ameliorating one or more symptoms of diseases associated with and/or caused by an abnormal blood glucose level. Further provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a cardiovascular disease.